Vaccines
Latest News
Pfizer COVID vaccine effective in young children, study shows
A three-dose series of the Pfizer COVID-19 vaccine was 73% effective at preventing symptomatic COVID-19 in children aged 6 months to 4 years.
From the Journals
COVID infection provides immunity equal to vaccination: Study
But protection against the BA.1 subvariant of Omicron was not as high.
From the Journals
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.
Latest News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”
Latest News
AAP approves 2023 child and adolescent immunization schedule
The updated recommendations do not include major changes from those released in 2022 by the Advisory Committee on Immunization Practices, except...
From the Journals
Maternal COVID-19 vaccine curbs infant infection
Maternal mRNA COVID-19 vaccination during pregnancy was less effective in protecting infants against omicron.
Feature
A technicality could keep RSV shots from kids in need
A glitch in congressional language may make it difficult to allow children from low-income families to get an RSV shot as readily as the well-...
Feature
More data back Guillain-Barré risk with Janssen COVID shot
Observed GBS cases after the Janssen shot were 2 to 3 times greater than expected, based on background rates within 21 and 42 days of vaccination...
Feature
COVID emergency orders ending: What’s next?
There will be cost-sharing changes for COVID-19 vaccines, testing, and certain treatments.